Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)
Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4473
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-4473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)
This text appears to be describing data related to cumulative incidence, with values ranging from 0.8 to 30%. The hazard ratio (HR) is reported to be 0.64 with a confidence interval of 0.50 to 0.83 and a statistically significant p-value of 0.0005. The data is reported over a span of 3.5 years.*
Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)
This description provides information about the effectiveness of Atorvastatin in reducing the risk of the primary endpoint over a four-year follow-up period. The hazard ratio is 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. The graph shows the time to the first primary endpoint.*
Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)
This text provides information on the subjects experiencing an event with different dosages of Atorvastatin, showing the hazard ratio and significance level for the comparison. It also includes data on the time to the first major cardiovascular endpoint in years.*
Remedy_label (Remedy Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
